Harbourvest Partners’s PMV Pharmaceuticals PMVP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-11,533
| Closed | -$17.2K | – | 34 |
|
|
2024
Q3 | $17.2K | Hold |
11,533
| – | – | 0.01% | 33 |
|
|
2024
Q2 | $18.7K | Hold |
11,533
| – | – | 0.01% | 37 |
|
|
2024
Q1 | $19.6K | Hold |
11,533
| – | – | 0.01% | 46 |
|
|
2023
Q4 | $35.8K | Hold |
11,533
| – | – | 0.01% | 50 |
|
|
2023
Q3 | $70.8K | Hold |
11,533
| – | – | 0.02% | 53 |
|
|
2023
Q2 | $72.2K | Hold |
11,533
| – | – | 0.02% | 55 |
|
|
2023
Q1 | $55K | Hold |
11,533
| – | – | 0.02% | 60 |
|
|
2022
Q4 | $100K | Hold |
11,533
| – | – | 0.03% | 59 |
|
|
2022
Q3 | $137K | Hold |
11,533
| – | – | 0.04% | 60 |
|
|
2022
Q2 | $164K | Hold |
11,533
| – | – | 0.05% | 56 |
|
|
2022
Q1 | $240K | Hold |
11,533
| – | – | 0.05% | 60 |
|
|
2021
Q4 | $266K | Buy |
11,533
+3,841
| +50% | +$88.6K | 0.03% | 56 |
|
|
2021
Q3 | $229K | Hold |
7,692
| – | – | 0.02% | 51 |
|
|
2021
Q2 | $263K | Hold |
7,692
| – | – | 0.03% | 45 |
|
|
2021
Q1 | $253K | Buy |
+7,692
| New | +$253K | 0.03% | 38 |
|